Literature DB >> 2138068

Experimental studies of immunologically mediated enteropathy. V. Destructive enteropathy during an acute graft-versus-host reaction in adult BDF1 mice.

A M Mowat1, M V Felstein.   

Abstract

As a means of investigating further the pathogenesis of intestinal immunopathology, we have attempted to produce a destructive enteropathy by inducing an acute graft-versus-host reaction (GVHR) in mature, immunocompetent mice. Adult (C57b1/10 X DBA/2)F1 (BDF1) mice given C57B1/10(B10) spleen cells develop a severe GVHR which is associated with marked weight loss and high mortality. In the intestine an initial phase of enteropathy characterized by intense crypt hyperplasia is replaced by more severe intestinal damage which includes villus atrophy and loss of intra-epithelial lymphocytes. These pathological alterations are paralleled by the generation of anti-host cytotoxic T lymphocytes (CTL), marked immunosuppression and the loss of natural killer (NK) cells. In contrast to these findings, adult BDF1 mice given DBA/2 donor cells do not develop an acute systemic GVHR and have no CTL or intestinal pathology, despite prolonged splenomegaly and enhanced NK cell activity. Thus, destructive enteropathy can be induced during a GVHR in intact hosts and our results confirm that this enteropathy has a biphasic pattern, with villus atrophy representing the progression of initial crypt hyperplasia in severe forms of disease associated with weight loss and specific CTL.

Entities:  

Mesh:

Year:  1990        PMID: 2138068      PMCID: PMC1534741          DOI: 10.1111/j.1365-2249.1990.tb05191.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Hypersensitivity reactions in the small intestine. III. The effects of allograft rejection and of graft-versus-host disease on epithelial cell kinetics.

Authors:  T T MacDonald; A Ferguson
Journal:  Cell Tissue Kinet       Date:  1977-07

Review 2.  Effects of local delayed hypersensitivity on the small intestine.

Authors:  A Ferguson; T T MacDonald
Journal:  Ciba Found Symp       Date:  1977 Apr 26-28

Review 3.  Natural killer cells.

Authors:  J C Roder; K Karre; R Kiessling
Journal:  Prog Allergy       Date:  1981

4.  Allosuppressor- and allohelper-T cells in acute and chronic graft-vs-host disease. IV. Activation of donor allosuppressor cells is confined to acute GVHD.

Authors:  S T Pals; T Radaszkiewicz; E Gleichmann
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

5.  Augmentation of intestinal and peripheral natural killer cell activity during the graft-versus-host reaction in mice.

Authors:  A Borland; A M Mowat; D M Parrott
Journal:  Transplantation       Date:  1983-11       Impact factor: 4.939

6.  Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.

Authors:  E Kubota; H Ishikawa; K Saito
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

7.  Intraepithelial lymphocyte count and crypt hyperplasia measure the mucosal component of the graft-versus-host reaction in mouse small intestine.

Authors:  A M Mowat; A Ferguson
Journal:  Gastroenterology       Date:  1982-08       Impact factor: 22.682

8.  Hypersensitivity reactions in the small intestine. 6. Pathogenesis of the graft-versus-host reaction in the small intestinal mucosa of the mouse.

Authors:  A M Mowat; A Ferguson
Journal:  Transplantation       Date:  1981-09       Impact factor: 4.939

9.  Capacity of genetically different T lymphocytes to induce lethal graft-versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells. A non-H-2 locus determines the inability to induce lethal graft-versus-host disease.

Authors:  E H Van Elven; A G Rolink; F V Veen; E Gleichmann
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

10.  Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. I. Alloreactive suppressor cells rather than killer T cells appear to be the decisive effector cells in lethal graft-vs.-host disease.

Authors:  A G Rolink; T Radaszkiewicz; S T Pals; W G van der Meer; E Gleichmann
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

View more
  10 in total

1.  Enteropathy in Zambians with HIV related diarrhoea: regression modelling of potential determinants of mucosal damage.

Authors:  P Kelly; S E Davies; B Mandanda; A Veitch; G McPhail; I Zulu; F Drobniewski; D Fuchs; C Summerbell; N P Luo; J O Pobee; M J Farthing
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

2.  Effects of gluten enriched diet on the small intestinal mucosa of normal mice and mice with graft versus host reaction.

Authors:  R Troncone; N Caputo; A Zibella; G Molitierno; L Maiuri; S Auricchio
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

3.  Effect of chronic graft-versus-host disease on the intestine in adult BDF1 mice.

Authors:  B de Geus; H Hogenesch; E de Heer; J A Bruijn; M van den Enden; J Rozing
Journal:  Int J Exp Pathol       Date:  1993-08       Impact factor: 1.925

4.  Differential cytokine production associated with distinct phases of murine graft-versus-host reaction.

Authors:  P Garside; S Reid; M Steel; A M Mowat
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

5.  The role of interferon alpha/beta in the induction of intestinal pathology in mice.

Authors:  P Garside; M V Felstein; E A Green; A M Mowat
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

6.  CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells.

Authors:  P J Morrissey; K Charrier; S Braddy; D Liggitt; J D Watson
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

7.  TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease.

Authors:  Riham El-Asady; Rongwen Yuan; Kechang Liu; Donghua Wang; Ronald E Gress; Philip J Lucas; Cinthia B Drachenberg; Gregg A Hadley
Journal:  J Exp Med       Date:  2005-05-16       Impact factor: 14.307

8.  Thymic selection and thymic major histocompatibility complex class II expression are abnormal in mice undergoing graft-versus-host reactions.

Authors:  J Desbarats; W S Lapp
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

9.  Effects of tumour necrosis factor-alpha on BrdU incorporation in cultured human enterocytes.

Authors:  J McDevitt; C Feighery; C O'Farrelly; G Martin; D G Weir; D Kelleher
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

10.  High dose multiple micronutrient supplementation improves villous morphology in environmental enteropathy without HIV enteropathy: results from a double-blind randomised placebo controlled trial in Zambian adults.

Authors:  John Louis-Auguste; Stephen Greenwald; Michelo Simuyandi; Rose Soko; Rose Banda; Paul Kelly
Journal:  BMC Gastroenterol       Date:  2014-01-15       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.